This result is in accordance with our observation that the cell subpopulation expressing increased levels of P-cadherin also presents higher levels of GLUT1 and CAIX, demonstrating that we are targeting the same breast cancer stem cell population. This evidence concerns the gene CA9 and breast cancer.